KBI Biopharma SA: KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland
The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities to serve the global demand for novel therapies. KBI Biopharma SA (KBI) and Selexis SA, both
Source: finanznachrichten.de